Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection

Journal of Perinatal Medicine

Volumn 40, Issue 2, 2012, Pages 185-189

  Basu, Sudeepta Kumar ^a   Chickajajur, Vijay ^a   Lopez, Vivian ^a   Bhutada, Alok ^a   Pagala, Murali ^b   Rastogi, Shantanu ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Magnesium; Mortality; Neuroprotection; Outcomes; Preterm neonates

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DRUG SAFETY; FEEDING BEHAVIOR; FEMALE; GESTATIONAL AGE; HUMAN; INTUBATION; LENGTH OF STAY; LUNG DYSPLASIA; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; NEWBORN; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RESUSCITATION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SURVIVAL RATE;

CEREBRAL PALSY; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MAGNESIUM; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENTS; PREGNANCY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84856909179     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.094     Document Type: Article

References (21)

1. ACOG, Society for Maternal-Fetal Medicine. Committee Opinion No. 455: magnesium sulphate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010;115: 669-71.
2. Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol. 2009;36:737-62.
3. Cahill AG, Caughey AB. Magnesium for neuroprophylaxis: fact or fiction? Am J Obstet Gynecol. 2009;200:590-4.
4. Crowther CA, Hiller JE, Doyle LW, Haslam RR. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J Am Med Assoc. 2003;290:2669-76. (Pubitemid 37475594)
5. Degos V, Loron G, Mantz J, Gressens P. Neuroprotective strategies for the neonatal brain. Anesth Analg. 2008;106: 1670-80.
6. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol. 2009;113:1327-33.
7. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;21:CD004661.
8. Gonen R. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol. 2010;115:186.
9. Handwerker SM, Altura BT, Jones KY, Altura BM. Maternalfetal transfer of ionized serum magnesium during the stress of labor and delivery: a human study. J Am Coll Nutr. 1995; 14:376-81.
10. Kruse M, Michelsen S, Flachs EM, Brønnum-Hansen H, Madsen M, Uldall P. Lifetime costs of cerebral palsy. Dev Med Child Neurol. 2009;51:622-8.
11. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. Br J Obstet Gynaecol. 2007;114:289-99.
12. Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, Delaporte B, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn with two-year neurologic outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;36: 278-88. (Pubitemid 351418284)
13. Martin JA, Kung HC, Mathews TJ. Annual summary of vital statistics 2006. Pediatrics. 2008;121:788-801.
14. Mittendorf R. Magnesium sulfate tocolysis: time to quit. Obstet Gynecol. 2007;109:1204-5. (Pubitemid 46685973)
15. Mittendorf R, Covert R, Boman J, Khoshnood B, Lee KS, Siegler M. Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet. 1997;350:1517-8. (Pubitemid 28036557)
16. Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianopoulos JG, Besinger RE, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;186:1111-8. (Pubitemid 34665044)
17. Mittendorf R, Dammann O, Lee K-S. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor. J Perinatol. 2006;26:57-63. (Pubitemid 43135257)
18. Mittendorf R, Stratford R, Khoshnood B, Lee KS, Pryde PG. Persistence of elevated serum magnesium levels in the neonate. Am J Obstet Gynecol. 2001;184:S50.
19. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics. 1995;95:263-9.
20. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol. 2006;33:251-67. (Pubitemid 43831170)
21. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Unites Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895-905.